Why Stifel is Buying Stitch Fix

Several FAANG names are due to report earnings this week

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     7/22/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Dow Pivots Lower; S&P, Nasdaq Higher With Chip Stocks By Patrick Martin Share On The Dow Jones Industrial Average (DJI) is lower at midday, erasing early morning gains as investors prepare for the latest batch of earnings reports, including several FAANG names set to report later this week. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are higher, though, enjoying modest gains thanks to semiconductor sector tailwinds. Elsewhere, the Fed's looming rate-cut decision at the July 30-31 Federal Open Market Committee (FOMC) meeting remains a talking point. According to CME Group’s FedWatch tool, market expectations for a 25 basis-point rate cut next week are at 77.5%. And earlier this morning, President Donald Trump tweeted that the Fed should "cut deeper."  Continue reading for more on today's market, including:  "The Lion King" has Disney stock eyeing record highs. Why Stifel is buying Stitch Fix stock. Plus, Teva puts pop; Applied Materials rides sector tailwinds; and a new bottom for Mallinckrodt stock. >> Continue reading...
LATEST HEADLINES
>> 2 Chinese Stocks Seeing Unusually Heavy Options Trading Calls have been popular on both names >> What ETF Flows Since the S&P June Low Can Tell Us Investors have poured $4B into a flat-lining bond play over the last seven weeks >> Amazon Stock Set to Snap Losing Streak on Pre-Earnings Bull Notes Two brokerage firms doled out price-target hikes ahead of Amazon's earnings report >> "The Lion King" Success Has Disney Stock Back Near Record Highs Disney stock is set to resume its long-term climb >> Stitch Fix Stock Pops as Another Analyst Screams "Buy" This is the second upgrade the stock has seen in as many weeks ADVERTISEMENT A Rare Opportunity to Turn $1,000 into $1.57 Million On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com